ANDA 77703, held by Sun Pharma Global. Pamidronate Disodium.
As of Nov 15, 2026, ANDA 77703 (Pamidronate Disodium), held by Sun Pharma Global, was first approved by FDA on Dec 24, 2008, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 24, 2008 | Original application | Approved | None posted |
| Pamidronate Disodium30MG/VIAL · injectable;injection | Pamidronate Disodium | Discontinued |
| Pamidronate Disodium90MG/VIAL · injectable;injection | Pamidronate Disodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
